For Immediate Release


Yvonne M. Psaila

Director of Marketing & Communications

Keystone Symposia on Molecular & Cellular Biology

+ 1 970-262-2676


Eileen Curran
Senior Director, Communications & Public Relations
National Multiple Sclerosis Society
+1 617-719-3202



Keystone Symposia Hosting Free Online Event on Multiple Sclerosis


SILVERTHORNE, CO – August 1, 2017 – Keystone Symposia is pleased to announce that on August 15, 2017, it will broadcast an online panel discussion on "Multiple Sclerosis: Conventional and Alternative Therapeutic Approaches" at 11:30 AM Eastern Time. Organized in collaboration with and sponsored by the National Multiple Sclerosis Society, this free event will feature approximately 60 minutes of panelist discussion followed by live audience Q&A with some of the panelists.


The event will be moderated by Dr. Bruce Bebo, Executive Vice President of Research for the National Multiple Sclerosis Society, and Dr. Patrizia Casaccia, Director of Neuroscience at the Advanced Science Research Center at CUNY. Joining them on the panel are Dr. Dennis Bourdette of Oregon Health & Science University, Dr. Ari Green of the University of California, San Francisco and Dr. Andrew Goodman of the University of Rochester Medical Center. Dr. Douglas Landsman, Associate Vice President of Biomedical Research at the National Multiple Sclerosis Society, will also join for the online Q&A.


It is estimated that 2.3 million individuals worldwide suffer from multiple sclerosis (MS), a neurodegenerative disease that occurs when the immune system attacks a fatty material called myelin that protects nerve cells. MS exhibits an extremely wide spectrum of clinical manifestations. While many strides have been made in treatment, particularly in the area of immunomodulatory and anti-inflammatory therapy, and some patients remain in a relapsing-remitting cycle, others suffer a more progressive form of the disease. There is an urgent need for new therapeutics for these patients, and there are exciting therapies on the horizon relating to stem cells/bone marrow transplants, immunoblation and drug therapies, as well as wellness approaches relating to diet.


According to Dr. Bruce Bebo, "We are thrilled to be partnering with Keystone Symposia on this online panel discussion. MS research is rapidly evolving, and this novel format allows for the timely communication of the latest research advances." Adds Dr. Patrizia Casaccia, "While current treatments have been remarkably effective in controlling relapses, there is increasing interest in therapies aimed at repairing damaged cells and restoring lost function. The goal of this webinar is to provide a forum for discussion on therapeutic approaches which bear the promise to meet these current unmet needs."


More information about this event can be found at While the event is free, advance registration is required. Viewers can submit questions for the panel either during online registration or via the chat room during the event itself.


About Virtual Keystone Symposia


Keystone Symposia has in the past held four-day conferences on multiple sclerosis, and MS is a component of many of its regular immunology and neurobiology conferences, including its Neuroinflammation conference, to be held next in June 2018. The new "Virtual Keystone Symposia" format is a way to hold forums on timely topics that can benefit from an accelerated production schedule. The format also serves as a way to share the scientific insights gained with a more extensive global audience. To date since this new programming model was launched a little over three years ago, more than 6,000 people have participated in Virtual Keystone Symposia events, which have been held on diverse topics including neuroscience, genome editing, noncoding RNAs, malaria, HIV antibodies and health disparities. All past events are available to view in archived form at



About Keystone Symposia on Molecular and Cellular Biology


Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Summit County, Colorado, USA since 1990. It will convene 60 face-to-face conferences in the 2017-2018 season, the majority of which will take place between January and April 2018, on topics ranging from cancer and immunology to neuroscience and genomics. Registration fees are supplemented by generous financial support from corporate, foundation and individual donors as well as government grants. More information about the organization and its meetings is located at and, respectively.


About the National Multiple Sclerosis Society

The Society mobilizes people and resources so that everyone affected by multiple sclerosis can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever. Last year alone, through our comprehensive nationwide network of services, the Society devoted more than $100 million to connect approximately one million people affected by MS to the connections, information and resources they need. To move closer to a world free of MS, the Society also invested $42 million to support more than 380 new and ongoing research projects around the world. We are united in our collective power to do something about MS now and end this disease forever. Learn more at Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the Society via its website or 1-800-344-4867.



About the Advanced Science Research Center at the Graduate Center, CUNY


The Advanced Science Research Center (ASRC) is the Graduate Center’s University-wide venture that elevates the City University of New York’s legacy of scientific research and education through initiatives in five distinctive, but increasingly interconnected disciplines: Nanoscience, Photonics, Structural Biology, Neuroscience and Environmental Sciences. The ASRC is designed to promote a unique, interdisciplinary research culture with researchers from each of the initiatives working side by side in the ASRC’s core facilities, sharing equipment that is among the most advanced available. More information is available at



About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms vary from person to person and range from numbness and tingling, to walking difficulties, fatigue, dizziness, pain, depression, blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million worldwide.